GlaxoSmythKline recently conducted safety trial studies on their new experimental Genital Herpes vaccine ‘Simplirix’. 8,323 women aged 18-30 years participated in the trial at 50 sites in the US & Canada. Based on the results the product has failed miserably. The question is why were these women infected with Herpes after vaccination with the virus? […]

Read More...